We track the growth of Pepsi, from its indigestion syrup origins, to the $247 billion global corporate behemoth it is today.
Must Read
Neuralink launches first clinical trial in Canada with regulatory approval
The trial will assess the safety and functionality of an implant designed to enable paralysed individuals to control digital devices using their thoughts